• Unique Test Screens for Recently Identified Peripheral Neuropathy: Matthew Schultz, Ph.D., and Amy White, M.S., CGC

  • 2024/09/24
  • 再生時間: 11 分
  • ポッドキャスト

Unique Test Screens for Recently Identified Peripheral Neuropathy: Matthew Schultz, Ph.D., and Amy White, M.S., CGC

  • サマリー

  • Matthew Schultz, Ph.D., and Amy White, M.S., CGC, explain how Mayo Clinic Laboratories' unique urine assay (Mayo ID: SORD) screens for peripheral neuropathy arising from SORD gene variants. Although recently identified, SORD-related peripheral neuropathy is fairly common.


    (00:31)
    Would you share a little bit about yourself and your background?

    (01:11)
    Could you provide us with an overview of this particular peripheral neuropathy?

    (03:09)
    Can you share the background as to how your team learned about this condition and how you considered testing for it?

    (04:42)

    Would you explain what you saw when you performed the urine test on the first patient?

    (05:26)
    Were you able to test additional patients with this condition?

    (06:09)

    Could you expand on why this urine test is important?

    (07:20)
    How does a health care provider order urine testing for SORD deficiency?

    (07:59)
    How does this new SORD urine test complement the existing Mayo Clinic Laboratories test menu?

    (08:55)

    Could you summarize the benefits of ordering this SORD urine test at Mayo?

    続きを読む 一部表示
activate_samplebutton_t1

あらすじ・解説

Matthew Schultz, Ph.D., and Amy White, M.S., CGC, explain how Mayo Clinic Laboratories' unique urine assay (Mayo ID: SORD) screens for peripheral neuropathy arising from SORD gene variants. Although recently identified, SORD-related peripheral neuropathy is fairly common.


(00:31)
Would you share a little bit about yourself and your background?

(01:11)
Could you provide us with an overview of this particular peripheral neuropathy?

(03:09)
Can you share the background as to how your team learned about this condition and how you considered testing for it?

(04:42)

Would you explain what you saw when you performed the urine test on the first patient?

(05:26)
Were you able to test additional patients with this condition?

(06:09)

Could you expand on why this urine test is important?

(07:20)
How does a health care provider order urine testing for SORD deficiency?

(07:59)
How does this new SORD urine test complement the existing Mayo Clinic Laboratories test menu?

(08:55)

Could you summarize the benefits of ordering this SORD urine test at Mayo?

Unique Test Screens for Recently Identified Peripheral Neuropathy: Matthew Schultz, Ph.D., and Amy White, M.S., CGCに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。